Integrated Cervical Cancer Screening in Mayuge District Uganda (ASPIRE Mayuge)

NACompletedINTERVENTIONAL
Enrollment

2,019

Participants

Timeline

Start Date

August 1, 2019

Primary Completion Date

July 31, 2021

Study Completion Date

October 31, 2022

Conditions
Human Papillomavirus 16Human Papillomavirus 18Papillomavirus InfectionsCervical CancerPre-Cancerous Dysplasia
Interventions
BEHAVIORAL

Self-collected HPV testing for cervical cancer screening

Self-collection cervical cancer screening, STI screening, and education on HIV by a community health worker. Women who test positive for high-risk HPV types will be referred to a designated health centre for VIA follow-up and treatment if indicated.

Trial Locations (1)

Unknown

Uganda Cancer Institute, Kampala

All Listed Sponsors
collaborator

Uganda Cancer Institute

OTHER

lead

University of British Columbia

OTHER

NCT04000503 - Integrated Cervical Cancer Screening in Mayuge District Uganda (ASPIRE Mayuge) | Biotech Hunter | Biotech Hunter